Jane F. Setterfield

Jane F. Setterfield

Auto-generated profile, based on publicly available information

Jane F. Setterfield

Department of Oral Medicine Guy's and St Thomas’ NHS Foundation Trust London UK

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2002 in Archives of Dermatology
Verified
Journal Article
Closed access
PDF file
LCLawrence S. Chan
Lawrence S. Chan
AAA. Razzaque Ahmed
A. Razzaque Ahmed
GAGrant J. Anhalt
Grant J. Anhalt
WBWolfgang Bernauer
Wolfgang Bernauer
KCKevin D. Cooper
Kevin D. Cooper
JZJohn J. Zone
John J. Zone
Objective We aimed to develop consensus-based recommendations for streamlining medical communication among various health care professionals, to improve accuracy of diagnosis and treatment, and to facilitate future investigations for mucous membrane pemphigoid. Participants Because of the highly specific nature of this group of diseases, the 26 invited participants included either international scholars in the field of mucous membrane pemphigoid or experts in cutaneous pharmacology representing the 3 medical disciplines ophthalmology, oral medicine, and dermatology. Evidence The first author (L.S.C.) conducted a literature search. Based on the information obtained, international experts who had contributed to the literature in the clinical care, diagnosis, and laboratory investigation for mucous membrane pemphigoid were invited to participate in a consensus meeting aimed at developing a consensus statement. Consensus Process A consensus meeting was convened and conducted on May 10, 1999, in Chicago, Ill, to discuss the relevant issues. The first author drafted the statement based on the consensus developed at the meeting and the participants' written comments. The draft was submitted to all participants for 3 separate rounds of review, and disagreements were reconciled based on literature evidence. The third and final statement incorporated all relevant evidence obtained in the literature search and the consensus developed by the participants. The final statement was approved and endorsed by all 26 participants. Conclusions Specific consensus-based recommendations were made regarding the definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators for mucous membrane pemphigoid. A system of standard reporting for these patients was proposed to facilitate a uniform data collection.

24 August 2020 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
PJP. Joly
P. Joly
BHB. Horvath
B. Horvath
ΑPΑ Patsatsi
Α Patsatsi
SUS. Uzun
S. Uzun
RBR. Bech
R. Bech
ESE. Schmidt
E. Schmidt

25 May 2016 in British Journal of Dermatology
Verified
Journal Article
Open access
PDF file
DCD Creamer
D Creamer
SWS A Walsh
S A Walsh
PDP Dziewulski
P Dziewulski
LEL S Exton
L S Exton
HLH Y Lee
H Y Lee
CSC H Smith
C H Smith

30 November 2017 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
KHK E Harman
K E Harman
DBD Brown
D Brown
LEL S Exton
L S Exton
RGR W Groves
R W Groves
PHP J Hampton
P J Hampton
PYP D Yesudian
P D Yesudian

17 August 2007 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
MEM. Escudier
M. Escudier
NAN. Ahmed
N. Ahmed
PSP. Shirlaw
P. Shirlaw
JSJ. Setterfield
J. Setterfield
ATA. Tappuni
A. Tappuni
SCStephen Challacombe
Stephen Challacombe

1 April 1998 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
JSJ Setterfield
J Setterfield
PSP J Shirlaw
P J Shirlaw
KMKerr- Muir
Kerr- Muir
SNS Neill
S Neill
BBB S Bhogal
B S Bhogal
MBM M Black
M M Black